MilliporeSigma
Sigma-Aldrich, GenOway Modify CRISPR Strategic Alliance
The companies struck a deal in 2018 allowing GenOway to develop rodent models using Sigma-Aldrich's CRISPR intellectual property.
Sigma-Aldrich Licenses CRISPR-Cas9 Tech to Horizon Discovery
The deal enables Horizon to support gene editing researchers who need cell-line engineering beyond loss-of-function CRISPR studies into CRISPR-mediated targeted knock-in.
MilliporeSigma Licenses Sigma-Aldrich CRISPR IP to Agbio Firm BetterSeeds
MilliporeSigma said that BetterSeeds will use the intellectual property to improve traits in cash crops such as cannabis and cowpea.
MilliporeSigma Licenses CRISPR-Cas9 Technology to Cellecta
Cellecta said it will use MilliporeSigma's technology to offer its customers CRISPR-mediated targeted gene knock-in services.
Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay.
Dec 19, 2019
MilliporeSigma Licenses CRISPR Tech to Promega
Apr 11, 2017
May 19, 2016
Nov 18, 2015
Merck KGaA Completes $17B Sigma-Aldrich Acquisition
Oct 29, 2015
Sigma-Aldrich Acquiring Olink's Duolink Line
Aug 11, 2015